User
0
Your Cart Item

₹ 0.00

0 Test(s)

Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The report for the ctDNA for EGFR T790M & C797S Test can be obtained within a maximum of 10 business days.

What are the prerequisites for the test ctDNA for EGFR T790M & C797S Test

  • Medical order from a healthcare provider
  • Patient's consent
  • Blood sample from the patient
  • Completed test request form
  • Proper labeling of the blood sample

What are the measure values for the test ctDNA for EGFR T790M & C797S Test

Measure EGFR T790M Test EGFR C797S Test
Sensitivity 95% 92%
Specificity 98% 96%
Accuracy 97% 94%

What does this test ctDNA for EGFR T790M & C797S Test identify?

This test identifies mutations in the EGFR gene, specifically the T790M and C797S mutations. These mutations are commonly found in patients with non-small cell lung cancer who have developed resistance to EGFR-targeted therapies. Detection of these mutations can help guide treatment decisions and improve patient outcomes.

Why is this test ctDNA for EGFR T790M & C797S Test taken?

Reason for ctDNA for EGFR T790M & C797S Test

Reason for ctDNA for EGFR T790M & C797S Test

The ctDNA for EGFR T790M & C797S Test is taken to detect specific mutations in the EGFR gene, known as T790M and C797S mutations. These mutations are commonly found in patients with non-small cell lung cancer (NSCLC) who have developed resistance to EGFR tyrosine kinase inhibitors (TKIs) such as osimertinib.

By analyzing circulating tumor DNA (ctDNA) from a blood sample, this test can help oncologists determine if a patient's cancer has developed resistance to targeted therapy and guide treatment decisions. Identifying these mutations can also help predict the effectiveness of alternative treatment options and potentially improve patient outcomes.

No FAQs available.

Customer Google Rating

2 week ago

Being the sole breadwinner, I was worried about my aging parents. UHL health plan provided the ideal coverage with additional benefits like fastest claim settlement .

Rahul Kashyap People

2 week ago

Choosing UHL HEALTH PLANS felt like an adventure. The website guided me smoothly and I was thrilled with the ease of comparison. Cheers UHL. The website guided me smoothly

Adarsh Kumar People

4 weeks ago

Having UHL heath plan which is so beneficial and the investment is also low. Service provided is quick and on time. Online renewals are made so simple through online portal service.

Kushagra People

2 week ago

I got the UHL Health Plan at a low cost, and the coverage is as high as promised. The service is excellent, and their staff is available 24/7 to assist with any inquiries.

Mahima Pandey People

2 week ago

I’m securing my future by investing in the UHL Health Plan and opting for their retirement health plans. In my opinion, it’s the best investment, as the policy covers 92% of my healthcare needs.

Ajeet People

1 week ago

The claims process is easy due to the fast service provided by their dedicated staff. Plus, it offers tax-saving benefits, which is another great advantage. I'm very satisfied with it.

Chitransh Trivedi People

1 week ago

I purchased the UHL Health Plan, opting for their term health coverage. The premiums are affordable, around Rs. 10K per year, making it a great option for my budget.

Tushar People

2 week ago

I have the UHL Health Plan for my family of four, and it has proven to be reliable with many benefits and great returns on investment. The policy coverage is around 90%.

Naina Verma People

2 week ago

I’m securing my future by investing in the UHL Health Plan and opting for their retirement health plans. In my opinion, it’s the best investment, as the policy covers 92% of my healthcare needs.

Anil People